+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

The Middle East and Africa Contraceptives Market 2019-2027

  • ID: 4772770
  • Report
  • Region: Africa, Middle East
  • 70 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 3

FEATURED COMPANIES

  • Afaxys, Inc.
  • Allergan Inc.
  • Church & Dwight Co., Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Okamoto Industries, Inc
  • MORE
Market Outlook

After a detailed analysis, the author has concluded in its report that the Middle East & Africa contraceptives market is projected to proliferate at a compound annual growth rate of 6.67% during the forecast period 2019-2027.

Excess use of contraceptive pills, especially by women belonging to Saudi Arabia is the largest factor driving the growth of the contraceptives market in this region. The South African government has ensured the implementation of various policies targeted at birth control. It has even developed facilities for the provision of contraceptives free-of-cost at various governmental healthcare institutions. STDs are highly prevalent in the African region; Contraceptives are extremely potent in the prevention of these STDs, and this is one of the vital reasons for the MEA contraceptives market growth.

The research report includes a detailed study of the market definition, market attractiveness index, market player positioning, regulatory outlook, key insights, Porter’s five forces analysis and Pestel outlook.

The country-wise economic development in Middle East & African region is uneven and highly fragmented. Unmet medical needs arise out of poor healthcare facilities in some of these countries, which in turn provides contraceptive manufacturers to set base in this market. The use of contraceptives, however, is not widely welcome in these countries due to social and religious norms, especially by the elderly population. Purchasing condoms may cause embarrassment to certain individuals. Fear pertaining to the use of IUDs and myths associated with the use of contraceptives are further challenging the market growth.

Competitive Outlook

Melbea, SMB Corporation, Church & Dwight Co., Inc., Reckitt Benckiser PLC, Allergan, Inc., Apothecus Pharmaceutical Corporation, Pfizer, Inc., Pregna, Afaxys, Inc., Merck & Co., Inc., Cooper Surgical, Inc., Ocon Medical, Ltd., Mayer Laboratories, Inc., Bayer AG, Okamoto Industries, Inc., Teva Pharmaceutical Industries, Ltd. and Agile Therapeutics are some of the companies manufacturing contraceptives.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Afaxys, Inc.
  • Allergan Inc.
  • Church & Dwight Co., Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Okamoto Industries, Inc
  • MORE
1. Contraceptive Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitute
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Threat of Competitive Rivalry
2.3. Regulatory Outlook
2.4. Pestel Outlook
2.5. Market Attractiveness Index
2.6. Market Player Positioning
2.7. Key Insights
2.7.1. Oral Contraceptive Are the Majorly Used Contraceptive Drugs
2.7.2. Condoms Are the Widely Used Contraceptives Device
2.7.3. Age Group of 15–24 Years Are the Major Revenue Contributors to the Contraceptive Market
2.8. Market Drivers
2.8.1. Growing Cognizance For Contraceptives
2.8.2. Increasing Usage of Oral Contraceptives to Evade Unplanned Pregnancy
2.8.3. Surge in the Initiatives of Government and Ngo
2.8.4. Growing Awareness About Std
2.9. Market Restraints
2.9.1. Side Effects Restricting the Growth of Contraceptives
2.9.2. Limited Access to Contraceptives
2.10. Market Opportunities
2.10.1. Rising Disposable Income in Emerging Economies
2.10.2. Unmet Medical Needs in the Emerging Economies
2.10.3. Technological Advancements
2.11. Market Challenges
2.11.1. Lack of Acceptance of Society

3. Contraceptive Market Outlook - By Education
3.1. Less Than High School
3.2. High School Graduate
3.3. College Graduate
3.4. Other College Degrees

4. Contraceptive Market Outlook - By Age Group
4.1. 15–24 Years
4.2. 25–34 Years
4.3. 35–44 Years
4.4. Above 44 Years

5. Contraceptive Market Outlook - By End User
5.1. Households
5.2. Clinics
5.3. Hospitals

6. Contraceptive Market Outlook - By Drugs and Devices
6.1. Contraceptives Drugs
6.1.1. Oral Contraceptive Pills
6.1.2. Injectable Contraceptives
6.1.3. Topical Contraceptives
6.2. Contraceptive Devices
6.2.1. Male Condoms
6.2.2. Female Condoms
6.2.3. Diaphragms
6.2.4. Contraceptive Sponges
6.2.5. Vaginal Rings
6.2.6. Subdermal Implants
6.2.7. Intra-Uterine Devices
6.2.7.1. Copper Intra-Uterine Devices
6.2.7.2. Hormonal Intra-Uterine Devices

7. Contraceptive Market - Regional Outlook
7.1.1. Country Analysis
7.1.1.1. United Arab Emirates
7.1.1.2. Turkey
7.1.1.3. Saudi Arabia
7.1.1.4. South Africa
7.1.1.5. Rest of the Middle East & Africa

8. Competitive Landscape
8.1. Company Profiles
8.1.1. Allergan Inc.
8.1.2. Bayer Ag
8.1.3. Melbea
8.1.4. Pregna
8.1.5. Pfizer, Inc.
8.1.6. Church & Dwight Co., Inc.
8.1.7. Afaxys, Inc.
8.1.8. Apothecus Pharmaceutical Corporation
8.1.9. Cooper Surgical Inc
8.1.10. Okamoto Industries, Inc
8.1.11. Mayer Laboratories, Inc.
8.1.12. Agile Therapeutics
8.1.13. Merck & Co., Inc.
8.1.14. Reckitt Benckiser Plc
8.1.15. Smb Corporation
8.1.16. Teva Pharmaceutical Industries Ltd.
8.1.17. Ocon Medical Ltd

9. Methodology & Scope
9.1. Research Scope
9.2. Sources of Data
9.3. Research Methodology

List of Tables
Table 1 the Middle East and Africa Contraceptive Market 2019-2027 ($ Million)
Table 2 Contraceptive Market Player Positioning Outlook 2017
Table 3 the Middle East and Africa Contraceptive Market By Education 2019-2027 ($ Million)
Table 4 the Middle East and Africa Contraceptive Market By Age Group 2019-2027 ($ Million)
Table 5 the Middle East and Africa Contraceptive Market By End User 2019-2027 ($ Million)
Table 6 the Middle East and Africa Contraceptive Market By Drugs and Devices 2019-2027 ($ Million)
Table 7 the Middle East and Africa Contraceptives Drugs Market By Type 2019-2027 ($ Million)
Table 8 the Middle East and Africa Contraceptive Devices Market By Type 2019-2027 ($ Million)
Table 9 the Middle East and Africa Intra-Uterine Devices Market By Type 2019-2027 ($ Million)
Table 10 the Middle East and Africa Contraceptive Market By Country 2019-2027 ($ Million)

List of Figures
Figure 1 the Middle East and Africa Contraceptive Market 2019-2027 ($ Million)
Figure 2 Porter's Five Force Model
Figure 3 the Middle East and Africa Contraceptive Market By Less Than High School 2019-2027 ($ Million)
Figure 4 the Middle East and Africa Contraceptive Market By High School Graduate 2019-2027 ($ Million)
Figure 5 the Middle East and Africa Contraceptive Market By College Graduate 2019-2027 ($ Million)
Figure 6 the Middle East and Africa Contraceptive Market By Other College Degrees 2019-2027 ($ Million)
Figure 7 the Middle East and Africa Contraceptive Market By 15–24 Years 2019-2027 ($ Million)
Figure 8 the Middle East and Africa Contraceptive Market By 25–34 Years 2019-2027 ($ Million)
Figure 9 the Middle East and Africa Contraceptive Market By 35–44 Years 2019-2027 ($ Million)
Figure 10 the Middle East and Africa Contraceptive Market By Above 44 Years 2019-2027 ($ Million)
Figure 11 the Middle East and Africa Contraceptive Market By Households 2019-2027 ($ Million)
Figure 12 the Middle East and Africa Contraceptive Market By Clinics 2019-2027 ($ Million)
Figure 13 the Middle East and Africa Contraceptive Market By Hospitals 2019-2027 ($ Million)
Figure 14 the Middle East and Africa Contraceptive Market By Contraceptives Drugs 2019-2027 ($ Million)
Figure 15 the Middle East and Africa Contraceptives Drugs Market By Oral Contraceptive Pills 2019-2027 ($ Million)
Figure 16 the Middle East and Africa Contraceptives Drugs Market By Injectable Contraceptives 2019-2027 ($ Million)
Figure 17 the Middle East and Africa Contraceptives Drugs Market By Topical Contraceptives 2019-2027 ($ Million)
Figure 18 the Middle East and Africa Contraceptive Market By Contraceptive Devices 2019-2027 ($ Million)
Figure 19 the Middle East and Africa Contraceptive Devices Market By Male Condoms 2019-2027 ($ Million)
Figure 20 the Middle East and Africa Contraceptive Devices Market By Female Condoms 2019-2027 ($ Million)
Figure 21 the Middle East and Africa Contraceptive Devices Market By Diaphragms 2019-2027 ($ Million)
Figure 22 the Middle East and Africa Contraceptive Devices Market By Contraceptive Sponges 2019-2027 ($ Million)
Figure 23 the Middle East and Africa Contraceptive Devices Market By Vaginal Rings 2019-2027 ($ Million)
Figure 24 the Middle East and Africa Contraceptive Devices Market By Subdermal Implants 2019-2027 ($ Million)
Figure 25 the Middle East and Africa Contraceptive Devices Market By Intra-Uterine Devices 2019-2027 ($ Million)
Figure 26 the Middle East and Africa Intra-Uterine Devices Market By Copper Intra-Uterine Devices 2019-2027 ($ Million)
Figure 27 the Middle East and Africa Intra-Uterine Devices Market By Hormonal Intra-Uterine Devices 2019-2027 ($ Million)
Figure 28 United Arab Emirates Contraceptive Market 2019-2027 ($ Million)
Figure 29 Turkey Contraceptive Market 2019-2027 ($ Million)
Figure 30 Saudi Arabia Contraceptive Market 2019-2027 ($ Million)
Figure 31 South Africa Contraceptive Market 2019-2027 ($ Million)
Figure 32 Rest of the Middle East and Africa Contraceptive Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Inc.
  • Bayer AG
  • Melbea
  • Pregna
  • Pfizer, Inc.
  • Church & Dwight Co., Inc.
  • Afaxys, Inc.
  • Apothecus Pharmaceutical Corporation
  • Cooper Surgical Inc
  • Okamoto Industries, Inc
  • Mayer Laboratories, Inc.
  • AGile Therapeutics
  • Merck & Co., Inc.
  • Reckitt Benckiser plc
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Ocon Medical
Note: Product cover images may vary from those shown
Adroll
adroll